Extracellular Bone Matrix and Bone Remodeling Environment (ECM)

The extracellular bone matrix (ECM) and the bone remodeling environment constitute a specialized physiological niche essential for skeletal integrity, mineral homeostasis, and hematopoiesis support. This environment consists of an organic framework, predominantly Type I collagen, and an inorganic mineral phase of hydroxyapatite, which together provide mechanical strength and act as a storage site for growth factors like TGF-beta and BMPs [1]. Bone remodeling is a continuous process involving the coordinated action of osteoclasts (resorption), osteoblasts (formation), and osteocytes (regulation), often referred to as the Basic Multicellular Unit (BMU) [2]. Pathological disruption of this environment is central to diseases such as osteoporosis, Paget's disease, and bone metastases, where the balance between resorption and formation is lost [3]. Pharmacological targeting of this environment involves antiresorptive drugs that inhibit osteoclast activity or anabolic agents that stimulate osteoblast function to restore bone mass and quality [4]. Understanding the biochemical and mechanical properties of this environment is crucial for developing treatments for metabolic bone diseases and skeletal complications of cancer [5]. References: [1] Florencio-Silva R, et al. (2015) BioMed Res Int. [2] Rowe P, et al. (2023) StatPearls. [3] Mundy GR. (2002) Nature Reviews Cancer. [4] Baron R, Hesse E. (2012) J Endocr Soc. [5] Pagani F, et al. (2021) Int J Mol Sci.

Other names

Bone microenvironmentBone extracellular matrixBone remodeling unitSkeletal matrix

Pharmacological modulation of the bone remodeling cycle through the inhibition of osteoclast-mediated resorption or the stimulation of osteoblast-mediated matrix deposition.